Home
>
US Stocks
>
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.
NBIX

Neurocrine Biosciences, Inc.

$104.5412.04%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
101.87
Today Low/High
101.87 / 106.04
52 Week Low/High
$84.77 / $120.27
P/E ratio
23.8
Market Cap
$8.68B

Company Details

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.
Organisation
Neurocrine Biosciences, Inc.
Headquaters
San Diego, California, US
Employees
845
Industry
Health Technology
CEO
Kevin Gorman

Discover more

Frequently Asked Questions

What is Neurocrine Biosciences, Inc. share price today

Can Indians buy Neurocrine Biosciences, Inc. shares?

How can I buy Neurocrine Biosciences, Inc. shares from India?

Can Fractional shares of Neurocrine Biosciences, Inc. be purchased?

What are the documents required to start investing in Neurocrine Biosciences, Inc. stocks?

We are a SEBI registered investement advisor